Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	43	non-cytoplasmic
44	68	transmembrane
69	94	cytoplasmic
95	120	transmembrane
121	151	non-cytoplasmic
152	171	transmembrane
172	182	cytoplasmic
183	204	transmembrane
205	220	non-cytoplasmic
221	245	transmembrane
246	257	cytoplasmic
258	281	transmembrane
282	309	non-cytoplasmic
310	335	transmembrane
336	350	cytoplasmic
351	372	transmembrane
373	387	non-cytoplasmic
388	409	transmembrane
410	429	cytoplasmic
430	448	transmembrane
449	452	non-cytoplasmic

Input:
>WP_111607942.1 NCBI__GCF_003259225.1:WP_111607942.1
MTNKTSIQGSWASRWIFILAATGSAVGLGNIWKFPYITGENGGGAFVLVYLACILLVGIP
IMMAEVFIGRRARKNPINALSDVAEESASSRKWGLIGVMGMLSGVLIFSFYSVVGGWVLH
YIKAMLTGEMSGISSDDAGAAFGALLADPATLLGWHTLFSIMTVVVVAAGINKGIETATR
IMMPALFVLLIILLGYAMTTGGFAQGWDFMFHFDFSKLTWNAALIALGHSFFTLSLGMGT
IMAYGSYMTKKASIGKTVLTIGALDTLVALVAGLAIFPIIFSNGMDPAAGPGLMFISLPV
AFGQMPFGQLFGTLFFVLVGVAAWTSAISLLEPTVAFLVERFKMKRITASIGLGVIVWGL
GIACLGSFNFMADVTFFGKNTFDFLDYITANIMLPLGGILIALFAGWVVKDKFAKDELET
SDTIYKLWNFSMKFTAPIAVAVVLYFLLNPIK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server